Ann: Clinical Study Shows Improvement to Diagnostic Standard, page-32

I agree with 13th. For me, the really attractive thing about Medibio as an investment has always been that it potentially offers a simple, cheap, easy to use way for an individual to assess the possibility that they might be depressed. "Possibility" is the key word. This is just a first step. The second step for that individual (now armed with the confidence that comes from the objective nature of the Medibio test) would be to talk to an appropriate professional - or maybe to talk to his/her employer about the result, who might (or more likely would have to) assist the employee to follow up on the result. Maybe, after further investigation, the individual is found not to be depressed. OK, so what? Nothing is lost. But if it turns out the individual can benefit from professional help then, actually, a great deal is potentially gained - especially compared to slogging on in a state of depression which may well be getting steadily worse.
So, to summarize, even at 70% accuracy, the cheap, objective, easy to use, Medibio test is in fact revolutionary in the field of diagnosing depression. Just wait and see.